Mingyo Kim

Mingyo Kim

Auto-generated profile, based on publicly available information

Mingyo Kim

Division of Rheumatology, Department of Internal Medicine and Institute of Medical Science, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, South Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HPHee Jin Park
Hee Jin Park
OJOk-Yi Jeong
Ok-Yi Jeong
SCsung hak Chun
sung hak Chun
CYCheon Yun-Hong
Cheon Yun-Hong
MKMingyo Kim
Mingyo Kim
SLSang-il Lee
Sang-il Lee
Systemic sclerosis (SSc) is an autoimmune disorder characterized by fibrosis of the skin and internal organs. Despite several studies on SSc treatments, effective treatments for SSc are still lacking. Since evidence suggests an association between intestinal microbiota and SSc, we focused on butyrate, which has beneficial effects in autoimmune diseases as a bacterial metabolite. Here, we investigated the therapeutic potential of sodium butyrate (SB) using a bleomycin-induced fibrosis mouse model of SSc and human dermal fibroblasts (HDFs). SB attenuated bleomycin-induced dermal and lung fibrosis in mice. SB influenced fecal microbiota composition (phyla Actinobacteria and Bacteroidetes, genera Bifidobacterium and Ruminococcus_g2). SB controlled macrophage differentiation in mesenteric lymph nodes, spleen, and bronchoalveolar lavage cells of mice with bleomycin-induced skin fibrosis. Profibrotic and proinflammatory gene expression was suppressed by SB administration in skin. Furthermore, SB inhibited transforming growth factor β1-responsive proinflammatory expression with increased acetylation of histone 3 in HDFs. Subcutaneous SB application had antifibrogenic effects on the skin. Butyrate ameliorated skin and lung fibrosis by improving anti-inflammatory activity in a mouse model of SSc. Butyrate may exhibit indirect and direct anti-fibrogenic action on fibroblasts by regulating macrophage differentiation and inhibition of histone deacetylase 3. These findings suggest butyrate as an SSc treatment.

12 August 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SYSeung-Ah Yoo
Seung-Ah Yoo
MKMingyo Kim
Mingyo Kim
MKMin-Cheol Kang
Min-Cheol Kang
JKJin-Sun Kong
Jin-Sun Kong
KKKi-Myo Kim
Ki-Myo Kim
WKWan-Uk Kim
Wan-Uk Kim

1 October 2018 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
CYCheon Yun-Hong
Cheon Yun-Hong
SLSeung-Geun Lee
Seung-Geun Lee
MKMingyo Kim
Mingyo Kim
HKHyun-Ok Kim
Hyun-Ok Kim
YSYoung Sun Suh
Young Sun Suh
SLSang-il Lee
Sang-il Lee

1 January 2022 in Immune Network
Verified
Journal Article
Open access
PDF file
MKMingyo Kim
Mingyo Kim
YCYong-ho Choe
Yong-ho Choe
SLSang-il Lee
Sang-il Lee
Kim M, et al. Immune Netw. 2022 Feb;22(1):e8. https://doi.org/10.4110/in.2022.22.e8

22 March 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
DKDongwon Kim
Dongwon Kim
MKMingyo Kim
Mingyo Kim
TKTae Woo Kim
Tae Woo Kim
YCYong-ho Choe
Yong-ho Choe
HNHae Sook Noh
Hae Sook Noh
SLSeung-Hyo Lee
Seung-Hyo Lee
Lymph node fibroblastic reticular cells (LN-FRCs) provide functional structure to LNs and play important roles in interactions between T cells and antigen-presenting cells. However, the direct impact of LN-FRCs on naive CD4+ T cell differentiation has not been explored. Here, we show that T cell zone FRCs of LNs (LN-TRCs) express CD25, the α chain of the IL-2 receptor heterotrimer. Moreover, LN-TRCs trans-present IL-2 to naive CD4+ T cells through CD25, thereby facilitating early IL-2–mediated signaling. CD25-deficient LN-TRCs exhibit attenuated STAT5 phosphorylation in naive CD4+ T cells during T cell differentiation, promoting T helper 17 (Th17) cell differentiation and Th17 response-related gene expression. In experimental autoimmune disease models, disease severity was elevated in mice lacking CD25 in LN-TRCs. Therefore, our results suggest that CD25 expression on LN-TRCs regulates CD4+ T cell differentiation by modulating early IL-2 signaling of neighboring, naive CD4+ T cells, influencing the overall properties of immune responses.

5 April 2022 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
LHLEE HANNA
LEE HANNA
YSYoung Sun Suh
Young Sun Suh
SLSang-il Lee
Sang-il Lee
CYCheon Yun-Hong
Cheon Yun-Hong
MKMingyo Kim
Mingyo Kim
HKHyun-Ok Kim
Hyun-Ok Kim
Objective: Insulin-like growth factor (IGF)-1 participates in modulating immunity and inflammation. Its bioactivity is controlled by six IGF-binding proteins (IGFBP-1 to IGFBP-6). In particular, the IGFBP-3 level is reportedly linked to the disease activity of rheumatoid arthritis (RA), consistent with our previous study. Therefore, the present study aimed to reproduce the previous results.Results: The serum IGFBP-3 level was not significantly different among the three groups according to disease activity based on the DAS28-ESR/CRP (p > 0.05) but was significantly different between the low- and high-disease-activity groups based on the DAS28-CRP (p = 0.036). Meanwhile, the interleukin-6 (IL-6) level moderately correlated with DAS28-CRP (Spearman’s rho = 0.583,p < 0.001).